Alain Moreau
Montreal, QC H3C3J7, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Haptoglobin Phenotypes Stratify Post-Exertional Cognitive Dysfunction Associated with Altered Cerebral Oxygenation and Metabolic Signatures in Long COVID.
Journal: International journal of molecular sciences
Published: June 23, 2026
Irisin Signaling Resistance in Myalgic Encephalomyelitis: A Proposed Mechanistic Framework for Post-Exertional Malaise Involving the TSP-1-HSP90α-αvβ5 Axis.
Journal: International journal of molecular sciences
Published: April 23, 2026
Raman Spectroscopy Combined with Machine Learning Reveals Myalgic Encephalomyelitis-Associated Biomolecular Signatures at Rest and After Standardized Stress.
Journal: International journal of molecular sciences
Published: March 27, 2026
Authors' Response to "Comment on 'SMPDL3B as a novel biomarker and therapeutic target in myalgic encephalomyelitis'".
Journal: Journal of translational medicine
Published: December 02, 2025
PTPRN2 hypomethylation and PHB2-associated miR-153-3p maturation define dual epigenetic features linked to symptom variability in Myalgic encephalomyelitis.
Journal: Journal of translational medicine
Published: December 02, 2025
Correction: SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis.
Journal: Journal of translational medicine
Published: August 14, 2025
Circulating Levels of SMPDL3B Define Metabolic Endophenotypes and Subclinical Kidney Alterations in Myalgic Encephalomyelitis.
Journal: International journal of molecular sciences
Published: July 22, 2025
Circulating FGF-21 as a Disease-Modifying Factor Associated with Distinct Symptoms and Cognitive Profiles in Myalgic Encephalomyelitis and Fibromyalgia.
Journal: International journal of molecular sciences
Published: July 03, 2025
Haptoglobin phenotypes and structural variants associate with post-exertional malaise and cognitive dysfunction in myalgic encephalomyelitis.
Journal: Journal of translational medicine
Published: May 31, 2025
UBC9-Mediated SUMO Pathway Drives Prohibitin-1 Nuclear Accumulation and PITX1 Repression in Primary Osteoarthritis.
Journal: International journal of molecular sciences
Published: May 29, 2025
SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis.
Journal: Journal of translational medicine
Published: April 10, 2025
A Perspective on the Role of Metformin in Treating Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long COVID.
Journal: ACS pharmacology & translational science
Published: March 31, 2025
Last Updated: 09/26/2026